Global Health Alerts: Investing in global infectious disease research - trends and inequities

Tuesday 13 November 2012

Venue: Royal Society of Medicine, 1 Wimpole Street, LONDON, W1G 0AE

Chaired by Professor David Heymann

Infectious diseases cause a very high burden of largely avoidable morbidity and mortality globally, and place significant strain on limited health budgets, the health systems and economies of affected countries. Since infections do not recognise borders, investments in R&D for infectious diseases will produce global public goods that have a positive impact both locally and globally regardless of the site of the work or the location of the institution receiving an award, bringing substantial health, social and economic benefit.

We present the first in-depth analysis of the UK contribution to infectious disease research, totalling £2.6 billion and including over 6000 studies. This includes data from all the major funders of infectious disease research. What proportion of the spend has gone into pre-clinical research compared to operational research? How much focus has the UK given to tuberculosis compared to HIV? And how much malaria funding is there compared to neglected tropical diseases? And who is doing the research? The results are being published in Lancet Infectious Diseases, and at this lecture we will discuss these critical issues and invite comment on future direction.

A panel discussion will follow the lecture. Panellists include Rifat Atun (Professor of International Health Management, Imperial College Business School), Sudeep Chand (Consultant Research Fellow, Centre on Global Health Security, Chatham House) and Richard Smith (Professor of Health System Economics, London School of Hygiene and Tropical Medicine)

A reception will take place after the panel discussion.

Speaker biography
Michael Head has been based at University College London since 2004, and is the manager of the Infectious Disease Research Network (www.idrn.org). Prior to this, he had worked at the Tavistock & Portman NHS Trust and in medical insurance for Royal & SunAlliance. His undergraduate degree was in Biomedical Sciences from University of Portsmouth and postgraduate study was in Epidemiology at the London School of Hygiene & Tropical Medicine.

He is also leading on the large analysis of research funding being presented this evening. The first peer-reviewed paper, and the research database, will likely be published in the autumn of 2012. Several other topic-specific papers are planned, with the assistance of expert collaborators. A website has been set up for the analysis, see www.researchinvestments.org for updates.


***This event is now fully booked - we will not be taking any further registrations***



6.30 pm

Registration opens

7.00 pm

Investing in global infectious disease research
Michael Head
Network Manager, Infectious Disease Research Network, University College London

7.45 pm

Panel discussion
Panellists include: Rifat Atun (Professor of International Health Management, Imperial College Business School) and Richard Smith (Professor of Health System Economics, London School of Hygiene and Tropical Medicine)

8.15 pm

Networking reception

Meeting ref: GHD02


Related information

Contact:

Events Team Manager:
Helen Whitman
Tel: +44 (0) 20 7290 3949
Fax: +44 (0) 20 7290 2989

Media Information:
Rosalind Dewar
Tel: +44 (0) 1580 764713